PGT-A (Preimplantation Genetic Testing for Aneuploidy) is a modern genetic test performed during the in vitro fertilization (IVF) process, aiming to assess the chromosomal count of embryos.

PGT-A represents one of the most significant advancements in modern reproductive medicine, integrating innovative technologies with precise diagnostics.

This test can determine whether an embryo has chromosomal abnormalities (e.g., extra or missing chromosomes), which are often the cause of implantation failure, spontaneous abortion, or genetic diseases.

The team at Beta Plus Clinic ensures reliability and care for each patient; therefore, PGT-A testing is conducted with high precision, utilizing modern laboratory technologies.

PGT-A is particularly recommended for:

• Patients over 35 years of age
• During repeated unsuccessful IVF cycles
• In cases of recurrent pregnancy loss
• To reduce genetic risks
• To improve embryo selection

As a result of testing, chromosomally healthy embryos can be selected, which increases the chances of successful implantation and achieving a healthy pregnancy.

Beta Plus Clinic offers professional services, an individualized approach, and continuous care – because your trust and successful outcome are paramount to us.